Related references
Note: Only part of the references are listed.ELLIPSE Study A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia
S. Dupuis-Girod et al.
MABS (2014)
Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management
Nathan B. Sautter et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2012)
Hereditary haemorrhagic telangiectasia Pathophysiology, diagnosis and treatment
Claire L. Shovlin
BLOOD REVIEWS (2010)
A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Roberto Zarrabeitia et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia
Jeffrey B. Hoag et al.
LARYNGOSCOPE (2010)
Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
C Sabbà et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)